Matthew W. Johnson
Matthew W. Johnson
Associate Professor of Psychiatry and Behavioral Sciences, Johns Hopkins University
Verified email at - Homepage
TitleCited byYear
Within‐subject comparison of real and hypothetical money rewards in delay discounting
MW Johnson, WK Bickel
Journal of the experimental analysis of behavior 77 (2), 129-146, 2002
Delay discounting in current and never-before cigarette smokers: similarities and differences across commodity, sign, and magnitude.
F Baker, MW Johnson, WK Bickel
Journal of abnormal psychology 112 (3), 382, 2003
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
RR Griffiths, WA Richards, MW Johnson, UD McCann, R Jesse
Journal of psychopharmacology 22 (6), 621-632, 2008
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
KA MacLean, MW Johnson, RR Griffiths
Journal of Psychopharmacology 25 (11), 1453-1461, 2011
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
RR Griffiths, MW Johnson, WA Richards, BD Richards, U McCann, ...
Psychopharmacology 218 (4), 649-665, 2011
Human hallucinogen research: guidelines for safety
MW Johnson, WA Richards, RR Griffiths
Journal of Psychopharmacology 22 (6), 603-620, 2008
An algorithm for identifying nonsystematic delay-discounting data.
MW Johnson, WK Bickel
Experimental and clinical psychopharmacology 16 (3), 264, 2008
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
RR Griffiths, MW Johnson, MA Carducci, A Umbricht, WA Richards, ...
Journal of Psychopharmacology 30 (12), 1181-1197, 2016
Delay discounting in currently using and currently abstinent cocaine-dependent outpatients and non-drug-using matched controls
SH Heil, MW Johnson, ST Higgins, WK Bickel
Addictive Behaviors 31 (7), 1290-1294, 2006
The behavioral economics of substance use disorders: reinforcement pathologies and their repair
WK Bickel, MW Johnson, MN Koffarnus, J MacKillop, JG Murphy
Annual review of clinical psychology 10, 641-677, 2014
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
MW Johnson, A Garcia-Romeu, MP Cosimano, RR Griffiths
Journal of Psychopharmacology 28 (11), 983-992, 2014
Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds
RR Griffiths, MW Johnson
Journal of Clinical Psychiatry 66 (supplement 9), 31-41, 2005
Moderate drug use and delay discounting: a comparison of heavy, light, and never smokers.
MW Johnson, WK Bickel, F Baker
Experimental and clinical psychopharmacology 15 (2), 187, 2007
Delay discounting in current and former marijuana-dependent individuals.
MW Johnson, WK Bickel, F Baker, BA Moore, GJ Badger, AJ Budney
Experimental and clinical psychopharmacology 18 (1), 99, 2010
Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population
PS Hendricks, CB Thorne, CB Clark, DW Coombs, MW Johnson
Journal of Psychopharmacology 29 (3), 280-288, 2015
Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects
MW Johnson, PE Suess, RR Griffiths
Archives of general psychiatry 63 (10), 1149-1157, 2006
Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction
A Garcia-Romeu, R R Griffiths, M W Johnson
Current drug abuse reviews 7 (3), 157-164, 2014
Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum
MW Johnson, KA MacLean, CJ Reissig, TE Prisinzano, RR Griffiths
Drug and alcohol dependence 115 (1-2), 150-155, 2011
Replacing relative reinforcing efficacy with behavioral economic demand curves
MW Johnson, WK Bickel
Journal of the experimental analysis of behavior 85 (1), 73-93, 2006
Factor analysis of the mystical experience questionnaire: A study of experiences occasioned by the hallucinogen psilocybin
KA MacLean, JMS Leoutsakos, MW Johnson, RR Griffiths
Journal for the scientific study of religion 51 (4), 721-737, 2012
The system can't perform the operation now. Try again later.
Articles 1–20